Drug-driving rise requires more than an annual licence check

Drug-driving endorsements have overtaken drink-driving offences, making impairment policy an immediate fleet priority.

Over 30,700 motorists received a drug driving endorsement on their driving licence in 2025 according to IAM RoadSmart data. That’s a 28% increase from 23,981 in 2022. Drink driving (DR10) endorsements fell by 17% over the same period, dropping from 35,976 to 29,769.

The issue includes prescription and over-the-counter medicines as well as illegal drugs. Fleet policies should clearly state that drivers must check medication warnings and report when they may be unfit to drive.

Annual licence checks remain important, but they only reveal an offence after it has occurred. Stronger risk management includes regular communication, manager awareness and clear escalation procedures when behaviour or performance changes.

Rules should apply equally to company vehicles, grey-fleet journeys and travel between work locations.

Fleet managers should also check whether drug and alcohol guidance is actively communicated or simply buried within a wider handbook.

A focused policy reminder, supported by clear medication and reporting guidance, could provide an immediate reduction in occupational road risk.

Similar Stories

Back to blog